Syncor Seeks SEC Filing Extension
Seeking more time to investigate possible bribes to foreign officials, nuclear medicine provider Syncor International Corp. said it will request a five-day extension for filing its Sept. 30 quarterly financial results with the Securities and Exchange Commission.
In a disclosure that cut its stock price in half last week, Syncor said it hired outside lawyers to investigate payments by its foreign subsidiaries.
The Woodland Hills company put its chairman, Monty Fu, and his brother, Moses Fu, on paid leave.
Syncor’s proposed buyout by drug distributor Cardinal Health Inc. is on hold while the companies investigate the questionable payments.
Syncor said it has turned up nothing to alter its financial results.
Its shares rose 95 cents to $22.88 on Nasdaq.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
